Literature DB >> 28144686

[New technical developments for inhaled sedation].

A Meiser1, H Bomberg2, T Volk2, H V Groesdonk2.   

Abstract

The circle system has been in use for more than 100 years, whereas the first clinical application of an anaesthetic reflector was reported just 15 years ago. In the circle system, all breathing gas is rebreathed after carbon dioxide absorption. A reflector, on the other hand, with the breathing gas flowing to and fro, specifically retains the anaesthetic during expiration and resupplies it during the next inspiration. A high reflection efficiency (number of molecules resupplied/number of molecules exhaled, RE 80-90%) decreases consumption. In analogy to the fresh gas flow of a circle system, pulmonary clearance ((1-RE) × minute ventilation) defines the opposition between consumption and control of the concentration.It was not until reflection systems became available that volatile anaesthetics were used routinely in some intensive care units. Their advantages, such as easy handling, and better ventilatory capabilities of intensive care versus anaesthesia ventilators, were basic preconditions for this. Apart from AnaConDa™ (Sedana Medical, Uppsala, Sweden), the new MIRUS™ system (Pall Medical, Dreieich, Germany) represents a second, more sophisticated commercially available system.Organ protective effects, excellent control of sedation, and dose-dependent deep sedation while preserving spontaneous breathing with hardly any accumulation or induction of tolerance, make volatile anaesthetics an interesting alternative, especially for patients needing deep sedation or when intravenous drugs are no longer efficacious.But obviously, the outcome is most important. We know that deep intravenous sedation increases mortality, whereas inhalational sedation could prove beneficial. We now need prospective clinical trials examining mortality, but also the psychological outcome of those most critically ill patients sedated by inhalation or intravenously.

Entities:  

Keywords:  AnaConDa™; Anaesthetic reflection; ICU sedation; Inhalation sedation; MIRUS™

Mesh:

Substances:

Year:  2017        PMID: 28144686     DOI: 10.1007/s00101-017-0269-5

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  44 in total

1.  Use of the AnaConDa anaesthetic delivery system to treat life-threatening asthma.

Authors:  H Thomson; N J Harper; A Parkes
Journal:  Anaesthesia       Date:  2007-03       Impact factor: 6.955

2.  [Functioning of the anaesthetic conserving device: aspects to consider for use in inhalational sedation].

Authors:  A Meiser; M Bellgardt; H Vogelsang; C Sirtl; T Weber
Journal:  Anaesthesist       Date:  2010-11       Impact factor: 1.041

3.  Isoflurane Ameliorates Acute Lung Injury by Preserving Epithelial Tight Junction Integrity.

Authors:  Joshua A Englert; Alvaro A Macias; Diana Amador-Munoz; Miguel Pinilla Vera; Colleen Isabelle; Jiazhen Guan; Brady Magaoay; Margarita Suarez Velandia; Anna Coronata; Awapuhi Lee; Laura E Fredenburgh; Deborah J Culley; Gregory Crosby; Rebecca M Baron
Journal:  Anesthesiology       Date:  2015-08       Impact factor: 7.892

4.  Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report.

Authors:  E M Brunt; H White; J W Marsh; B Holtmann; M G Peters
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

5.  Inhalation versus endovenous sedation in subarachnoid hemorrhage patients: effects on regional cerebral blood flow.

Authors:  Federico Villa; Cosimo Iacca; Andrea Forastieri Molinari; Carlo Giussani; Giacomo Aletti; Antonio Pesenti; Giuseppe Citerio
Journal:  Crit Care Med       Date:  2012-10       Impact factor: 7.598

6.  Carbon dioxide rebreathing with the anaesthetic conserving device, AnaConDa®.

Authors:  L W Sturesson; G Malmkvist; M Bodelsson; L Niklason; B Jonson
Journal:  Br J Anaesth       Date:  2012-04-13       Impact factor: 9.166

7.  Survival after long-term isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients: Retrospective analysis.

Authors:  Martin Bellgardt; Hagen Bomberg; Jenny Herzog-Niescery; Burkhard Dasch; Heike Vogelsang; Thomas P Weber; Claudia Steinfort; Waldemar Uhl; Stefan Wagenpfeil; Thomas Volk; Andreas Meiser
Journal:  Eur J Anaesthesiol       Date:  2016-01       Impact factor: 4.330

8.  Anaesthetic conserving device AnaConDa: dead space effect and significance for lung protective ventilation.

Authors:  L W Sturesson; M Bodelsson; B Jonson; G Malmkvist
Journal:  Br J Anaesth       Date:  2014-05-28       Impact factor: 9.166

9.  Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies.

Authors:  James S Anderson; Noel R Rose; Jackie L Martin; Edmond I Eger; Dolores B Njoku
Journal:  Anesth Analg       Date:  2007-06       Impact factor: 5.108

Review 10.  Volatile Anesthetics. Is a New Player Emerging in Critical Care Sedation?

Authors:  Angela Jerath; Matteo Parotto; Marcin Wasowicz; Niall D Ferguson
Journal:  Am J Respir Crit Care Med       Date:  2016-06-01       Impact factor: 21.405

View more
  1 in total

1.  [Treatment of extreme anemia with polymerized bovine hemoglobin : Case report and review of the literature].

Authors:  A Meiser; H Knoll; T Meisel; M Schröder; T Volk
Journal:  Anaesthesist       Date:  2020-10-01       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.